{"filing":{"accession_number":"0001683168-26-007973","cik":"0002039072","ticker":"DAVI","company_name":"DAVION HEALTHCARE PLC","form":"6-K","filing_date":"2026-10-20","report_date":"2026-10-20","primary_document":"davion_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2039072/000168316826007973/davion_6k.htm"},"events":[{"id":36335,"run_id":33498,"accession_number":"0001683168-26-007973","anchor_item_number":"EX-99.1","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"The press release announces the appointment of Glenn Williams as Chief Executive Officer and Jeremy North as Chief Operating Officer, both effective upon Nasdaq commencement of trading on 22 October 2026. While the release also discloses Jack Kaye's transition from CEO to Chairman and Sir Eric Peacock's step-down as Chairman, the principal disclosed action is the appointment of two new senior executives to lead the company's operations and growth strategy. This is material to investors as it represents a significant leadership transition at a newly public company.","company_name":"DAVION HEALTHCARE PLC","ticker":"DAVI","filing_date":"2026-10-20","form":"6-K","submitted_at":null,"items":[{"id":40721,"accession_number":"0001683168-26-007973","item_number":"EX-99.1","item_title":"davion_ex9901.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The press release announces the appointment of Glenn Williams as Chief Executive Officer and Jeremy North as Chief Operating Officer, both effective upon Nasdaq commencement of trading on 22 October 2026. While the release also discloses Jack Kaye's transition from CEO to Chairman and Sir Eric Peacock's step-down as Chairman, the principal disclosed action is the appointment of two new senior executives to lead the company's operations and growth strategy. This is material to investors as it represents a significant leadership transition at a newly public company.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-20T13:50:37.937555+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":40721,"accession_number":"0001683168-26-007973","item_number":"EX-99.1","item_title":"davion_ex9901.htm","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The press release announces the appointment of Glenn Williams as Chief Executive Officer and Jeremy North as Chief Operating Officer, both effective upon Nasdaq commencement of trading on 22 October 2026. While the release also discloses Jack Kaye's transition from CEO to Chairman and Sir Eric Peacock's step-down as Chairman, the principal disclosed action is the appointment of two new senior executives to lead the company's operations and growth strategy. This is material to investors as it represents a significant leadership transition at a newly public company.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-20T13:50:37.937555+00:00","company_name":"DAVION HEALTHCARE PLC","ticker":"DAVI","filing_date":"2026-10-20"}]}